Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients.
Xpert® NPM1 Mutation
Quantitative assay of the NPM1 mRNA transcripts (Type A, B, and D) and the ABL1 endogenous control mRNA transcript in EDTA peripheral blood samples. For Research Use Only (RUO). Not for use in diagnostic procedures.